News Coronavirus Update on treatments and vaccines against Covid-19 under development

Update on treatments and vaccines against Covid-19 under development

The European Medicines Agency says supporting the rapid development and approval of effective and safe treatments for and vaccines against COVID-19 is EMA’s top priority to help save lives during the pandemic.

Over recent weeks and months, the Agency has engaged with many developers of therapeutic medicines and there are a number of developments underway. However, at this point, on the basis of the preliminary data presented to the Agency, no medicine has yet demonstrated efficacy in treating COVID-19.

EMA’s COVID-19 response team has been in contact with developers of around 40 therapeutic medicines, allowing better understanding of potential treatments.

Among the potential treatments for COVID-19 that are undergoing clinical trials to assess their safety and efficacy against the disease are:

  • remdesivir (investigational)
  • lopinavir/ritonavir (currently authorised as an anti-HIV medicine)
  • chloroquine and hydroxychloroquine (currently authorised at national level as treatments against malaria and certain autoimmune diseases such as rheumatoid arthritis)
  • systemic interferons and in particular interferon beta (currently authorised to treat diseases such as multiple sclerosis)
  • monoclonal antibodies with activity against components of the immune system

EMA welcomes the launch of large clinical trials as they are necessary to generate the robust data needed to establish evidence for which medicines do work and thus to give appropriate advice to healthcare professionals and patients and enable regulatory decision-making, as advised by EMA’s human medicines committee (CHMP).

The Agency has also had discussions with developers of a dozen potential COVID-19 vaccines. Two vaccines have already entered phase I clinical trials, which are the first trials needed and are carried out in healthy volunteers. In general, timelines for the development of medicinal products are difficult to predict.

Based on the information currently available and past experience with vaccine development timeframes, EMA estimates that it might take at least one year before a vaccine against COVID-19 is ready for approval and available in sufficient quantities to enable widespread use. Adequate supply of doses to meet the needs of all EU countries has to be proactively forecast.

EMA’s response team will continue to interact with developers of potential therapeutics or vaccines against COVID-19. The aim is to provide advice on regulatory requirements so that any promising medicinal product can be made available as rapidly as possible to patients, initially in the clinical trial setting and then, once authorised, on the market.

Top Stories

160 new cases of COVID-19 on Friday

The Health Ministry announced 160 new COVID-19 cases on 23 October, out of 4,327 laboratory tests, taking confirmed infections to 3,314. The break-down of new...

Health Ministry insists there is confirmed case among American Center staff

The Health Ministry replied to the denial of the American Medical Center regarding a confirmed case among its staff. In an announcement the Ministry noted...

Health Ministry replies to accusation about delay of the tracing unit

The tracing unit contacts the persons who have tested positive to COVID-19 as soon as it is informed by the relevant laboratories and the...

Professor of Microbiology concerned about asymptomatic patients

Dr Petros Karayiannis, Professor of Microbiology/Molecular Virology at the University of Nicosia Medical School, has expressed concern over the great number of private hospitals,...

30-year-old missing for seven months (PHOTO)

Police are looking for 30-year old NAKITA YASMEEN from the United Kingdom, whose traces have been lost since March 2020. Yasmeen’s disappearance was today...

Taste

Squash soup

Ingredients: 1 kg pumpkin, cut into small cubes, approximately 5 cups 2 medium (400g) sweet potatoes, cut into cubes, approximately 2 ½ cups 1 chopped leek, only...

Mezedes

No visit to Cyprus is complete without enjoying the traditional meal of many small dishes known as ‘meze’. This large feast, which has been a...

Prawns with fried cheese, barley shaped pasta

Put the barley shaped pasta into a small pan with salted water, bring to a boil and when tender, drain. Peal the prawns leaving...

Salmon and shrimp sheftalies

Mix all ingredients for tabbouli in a bowl and keep to one side so flavours can combine. Prepare the sheftalies: wash and soak the casing...